169 related articles for article (PubMed ID: 37157017)
21. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
22. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
24. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
López-Corral L; Caballero-Velázquez T; López-Godino O; Rosiñol L; Pérez-Vicente S; Fernandez-Avilés F; Krsnik I; Morillo D; Heras I; Morgades M; Rifon JJ; Sampol A; Iniesta F; Ocio EM; Martin J; Rovira M; Cabero M; Castilla-Llorente C; Ribera JM; Torres-Juan M; Moraleda JM; Martinez C; Vázquez A; Gutierrez G; Caballero D; San Miguel JF; Mateos MV; Pérez-Simón JA
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1703-1712. PubMed ID: 31054983
[TBL] [Abstract][Full Text] [Related]
25. [Comparative analysis between autologous and allogeneic hematopoietic stem cell transplantation in 114 adult patients with acute lymphoblastic leukemia in long-term follow-up].
Bao YS; Jiang EL; Wang M; Wang H; Huang Y; Wei JL; Yang DL; Feng SZ; Qiu LG; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1325-9. PubMed ID: 19099637
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
27. Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.
Huang WR; Liu DH
Chin Med J (Engl); 2018 Sep; 131(17):2105-2111. PubMed ID: 30127221
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
Murashige N; Kami M; Kishi Y; Kim SW; Takeuchi M; Matsue K; Kanda Y; Hirokawa M; Kawabata Y; Matsumura T; Kusumi E; Hirabayashi N; Nagafuji K; Suzuki R; Takeuchi K; Oshimi K
Br J Haematol; 2005 Aug; 130(4):561-7. PubMed ID: 16098071
[TBL] [Abstract][Full Text] [Related]
29. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
[TBL] [Abstract][Full Text] [Related]
30. [Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation].
Yin Y; Qiu ZX; Li Y; Xu WL; Sun YH; Liu W; Wang WS; Wang MJ; Wang LH; Dong YJ; Ou JP; Cen XN; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):418-425. PubMed ID: 28446286
[TBL] [Abstract][Full Text] [Related]
31. [Clinical outcomes of peripheral blood stem cell transplantation for aggressive peripheral T-cell lymphoma].
Huang WR; Gu ZY; Li HH; Bo J; Wang SH; Li F; Gao XN; Dou LP; Zhao Y; Jing Y; Zhu HY; Wang QS; Yu L; Gao CJ; Liu DH
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):729-733. PubMed ID: 30369182
[No Abstract] [Full Text] [Related]
32. Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation.
Manson G; Mear JB; Herbaux C; Schiano JM; Casasnovas O; Stamatoullas A; Deau B; Schmitt A; Garnier G; Regny C; Bouabdallah K; Moles-Moreau MP; Ghesquieres H; Tempescul A; Dulery R; Nicolas-Virelizier E; Delmer A; Borel C; Chauchet A; Damotte D; Dercle L; Brice P; Houot R;
Eur J Cancer; 2019 Jul; 115():47-56. PubMed ID: 31082693
[TBL] [Abstract][Full Text] [Related]
33. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
Yasuda S; Najima Y; Konishi T; Yamada Y; Nagata A; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Shingai N; Yoshioka K; Inamoto K; Mukae J; Toya T; Igarashi A; Shimizu H; Kobayashi T; Kakihana K; Sakamaki H; Kawamata N; Ohashi K; Doki N
Leuk Res; 2021 Sep; 108():106627. PubMed ID: 34062327
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of treatment response and prognostic factors of T-LBL patients treated with pediatric-like ALL therapy following HSCT].
Wang HT; Dong Y; Gao XT; Wan Z; Zhao YX; Liu YM; Liu L
Zhonghua Xue Ye Xue Za Zhi; 2020 May; 41(5):387-393. PubMed ID: 32536135
[No Abstract] [Full Text] [Related]
35. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma.
Inoue Y; Fuji S; Tanosaki R; Inamoto Y; Tanaka T; Ito A; Okinaka K; Kurosawa S; Kim SW; Nakagama H; Fukuda T
Bone Marrow Transplant; 2018 Sep; 53(9):1105-1115. PubMed ID: 29523883
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
37. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
38. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
[TBL] [Abstract][Full Text] [Related]
39. Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation.
Ijaz A; Khan AY; Malik SU; Faridi W; Fraz MA; Usman M; Tariq MJ; Durer S; Durer C; Russ A; Parr NNC; Baig Z; Sagar F; Ali Z; McBride A; Anwer F
Biol Blood Marrow Transplant; 2019 Jan; 25(1):94-99. PubMed ID: 30195074
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT.
Gutiérrez-García G; Martínez C; Boumendil A; Finel H; Malladi R; Afanasyev B; Tsoulkani A; Wilson KMO; Bloor A; Nikoloudis M; Richardson D; López-Corral L; Castagna L; Cornelissen J; Giltat A; Collin M; Fanin R; Bonifazi F; Robinson S; Montoto S; Peggs KS; Sureda A
Br J Haematol; 2022 Feb; 196(4):1018-1030. PubMed ID: 34750806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
